quinoline has been researched along with Acute Confusional Senile Dementia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Alsaab, HO; Aqsa, S; Asif, TT; Ibrar, A; Kausar, N; Khan, I; Munir, R; Shahid, N; Younas, MT; Zaib, S | 1 |
| de Almeida, JSFD; de Oliveira C Brum, J; Figueroa-Villar, JD; França, TCC; Kuca, K; Lima, JA; Neto, DCF | 1 |
| Athar, MM; Awan, SJ; Iftikhar, K; Javid, N; Khan, I; Munir, R; Murtaza, S; Zaib, S; Zia-Ur-Rehman, M | 1 |
| Akbarzadeh, T; Babaee, S; Chehardoli, G; Homayouni Moghadam, F; Mahdavi, M; Najafi, Z; Rastegari, A; Zolfigol, MA | 1 |
| Chen, Y; Chen, Z; He, Q; Huang, G; Huang, Z; Wang, X | 1 |
| Arancio, O; Deng, SX; Fiorito, J; Landry, DW; Saeed, F; Staniszewski, A; Vendome, J; Yan, S; Zhang, H | 1 |
| Karahisar, E; Orhan, IE; Sahin, M; Sezer Senol Deniz, F; Skalicka-Wozniak, K; Tugay, O; Vlad Luca, S | 1 |
| Akbarzadeh, T; Edraki, N; Foroumadi, A; Karimpor-Razkenari, E; Khanavi, M; Mahdavi, M; Moghadam, FH; Najafi, Z; Sabourian, R; Saeedi, M; Shafiee, A; Sharifzadeh, M; Tehrani, MB | 1 |
| Guo, QL; Huang, SL; Huang, ZS; Li, D; Liu, ZQ; Ou, TM; Tan, JH; Wang, HG; Wang, N; Wu, JQ; Xia, CL | 1 |
| Andrisano, V; Badia, A; Bartolini, M; Bidon-Chanal, A; Camps, P; Clos, MV; Dafni, T; Formosa, X; Galdeano, C; Gómez, E; Gómez, T; Huertas, O; Isambert, N; Lavilla, R; Luque, FJ; Mancini, F; Muñoz-Torrero, D; Ramírez, L; Viayna, E | 1 |
| Astudillo-Saavedra, L; Guzmán, L; Maccioni, RB; Navarrete, LP; San Martín, A | 1 |
| Arancio, O; Deng, SX; Feng, Y; Fiorito, J; Francis, YI; Landry, DW; Rao, S; Saeed, F; Staniszewski, A; Thakkar, DM; Zhang, H | 1 |
| Clader, JW; Gu, H; Guo, T; Hobbs, DW; Jacob, B; Rokosz, LL; Stauffer, TM | 1 |
13 other study(ies) available for quinoline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Humans; Models, Molecular; Neuroprotective Agents; Quinolines; Thiosemicarbazones | 2021 |
Synthesis of New Quinoline-Piperonal Hybrids as Potential Drugs against Alzheimer's Disease.
Topics: Alzheimer Disease; Benzaldehydes; Benzodioxoles; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Humans; Kinetics; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Quinolines; Structure-Activity Relationship | 2019 |
Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cell Line, Tumor; Cell Proliferation; Cholinesterase Inhibitors; Cholinesterases; Hep G2 Cells; Heterocyclic Compounds; Humans; Hydrazines; Microwaves; Molecular Docking Simulation; Quinolines; Structure-Activity Relationship; Thioamides | 2021 |
Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Electrophorus; Horses; Hydrogen Peroxide; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; PC12 Cells; Pyridines; Pyrones; Quinolines; Rats; Tacrine | 2021 |
The protection of novel 2-arylethenylquinoline derivatives against impairment of associative learning memory induced by neural Aβ in C. elegans Alzheimer's disease model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Association Learning; Caenorhabditis elegans; Disease Models, Animal; Memory; Neuroprotective Agents; Quinolines | 2017 |
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Binding Sites; Cyclic AMP Response Element-Binding Protein; Cyclic GMP; Humans; Mice; Molecular Docking Simulation; Naphthyridines; Phosphodiesterase 5 Inhibitors; Quinolines; Solubility; Structure-Activity Relationship | 2017 |
Metabolite Profiling by Hyphenated Liquid Chromatographic Mass Spectrometric Technique (HPLC-DAD-ESI-Q-TOF-MS/MS) and Neurobiological Potential of Haplophyllum sahinii and H. vulcanicum Extracts.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Coumarins; Humans; Lignans; Plant Extracts; Quinolines; Rutaceae; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Turkey | 2019 |
Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.
Topics: Acridines; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Chromones; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; PC12 Cells; Quinolines; Rats; Structure-Activity Relationship | 2016 |
Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Cell Death; Cell Line; Cholinesterase Inhibitors; Drug Design; Glutathione; Humans; Quinolines; Reactive Oxygen Species | 2017 |
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.
Topics: Acetylcholinesterase; Alzheimer Disease; Amino Acid Motifs; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Catalytic Domain; Cholinesterase Inhibitors; Donepezil; Drug Discovery; Humans; Indans; Models, Molecular; Piperidines; Protein Multimerization; Protein Structure, Quaternary; Quinolines; Tacrine | 2010 |
Molecules of the quinoline family block tau self-aggregation: implications toward a therapeutic approach for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Cattle; Cell Line, Tumor; Humans; Protein Binding; Protein Structure, Tertiary; Quinolines; tau Proteins | 2012 |
Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Drug Discovery; Female; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Phosphodiesterase 5 Inhibitors; Quinolines | 2013 |
Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Carbamates; Drug Design; Enzyme Inhibitors; Humans; Pyrrolidines; Quinolines; Structure-Activity Relationship; Sulfonamides | 2007 |